# FDA Inspection 1201349 - CSL Plasma Inc. - March 29, 2023

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/326bd3d0-7f5d-4ba7-a5cd-cc8202993fea
Source feed: FDA_Inspections

> FDA Inspection 1201349 for CSL Plasma Inc. on March 29, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201349
- Company Name: CSL Plasma Inc.
- Inspection Date: 2023-03-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1031982 - 2017-10-31](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/4e887588-61f5-4693-aea2-465903956e5c)
- [FDA Inspection 985201 - 2016-07-07](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/316ecbff-7943-4e97-a4e7-641c558e9865)

Company: https://www.keypedia.com/companies/csl-plasma-inc/573d3bf3-ca94-4e4f-8155-2d3118aa36bb

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d